Positive Results For Dyax
Dyax Corp. (DYAX) announced positive results for its genetic disease drug trial sending the stock price soaring $1.97 to close at $5.97.
posted by FC Market News at 9:12 AM
Friday, April 13, 2007
Previous Posts
- Nautilus Lowers Guidance
- IPSCO Confirms Sale Rumors
- MedImmune May Sell Itself
- Allen Systems To Buy Mobius
- Marinemax Warns Of Slowing Sales
- Interphase Lowers Outlook
- American Medical Systems Warns
- Fast Track Status For Cell Therapeutics'
- Tractor Supply Reports Higher Revenue
- CheckFree Downgraded
0 Comments:
Post a Comment
<< Home